Author:
Slee P. H. Th. J.,Van Oosterom A. T.,De Bruijn E. A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. Skipper HE, Schabel FM jr. Tumour Stem Cell Heterogeneity: Implications with Respect to Classification of Cancers by Chemotherapeutic Effect. Cancer Treat Rep 1984;68:43–61.
2. Goodman LS, Wintrobe MM, Dameshek W, et al. Nitrogen mustard therapy: use of methylbis(β-chlorethyl)amino hydrochloride for Hodgkin's disease, lymphosarcoma, and certain allied and miscellaneous disorders. JAMA 1946;132:126–32.
3. Armstrong RD, Diasio RB. Selective activation of 5′-Deoxy-5-fluorouridine by tumour cells as a basis for an improved therapeutic index. Cancer Res 1981;41:4891–4.
4. Driscoll JS. The Preclinical New Drug Research Program of the National Cancer Institute. Cancer Treat Rep 1984;68:63–76.
5. Goldin A, Venditti JM, MacDonald JS, Muggia FM, Henney JE, De Vita VT. Current Results of the Screening Program at the Division of Cancer Treatment, National Cancer Institute. Eur J Cancer 1981;17:129–44.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献